NO962406L - Farmasöytisk formulering for profylakse henholdsvis for behandling av en forgiftning ved fosfororganiske kolinesterasehemmere - Google Patents

Farmasöytisk formulering for profylakse henholdsvis for behandling av en forgiftning ved fosfororganiske kolinesterasehemmere

Info

Publication number
NO962406L
NO962406L NO962406A NO962406A NO962406L NO 962406 L NO962406 L NO 962406L NO 962406 A NO962406 A NO 962406A NO 962406 A NO962406 A NO 962406A NO 962406 L NO962406 L NO 962406L
Authority
NO
Norway
Prior art keywords
prophylaxis
pharmaceutical formulation
poisoning
cholinesterase inhibitors
treatment
Prior art date
Application number
NO962406A
Other languages
English (en)
Norwegian (no)
Other versions
NO962406D0 (no
Inventor
Thomas Hille
Walter Muller
Bodo Asmussen
Aharon Levy
Yacov Meshulam
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6504683&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO962406(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO962406L publication Critical patent/NO962406L/no
Publication of NO962406D0 publication Critical patent/NO962406D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Addiction (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO962406A 1993-12-10 1996-06-07 Farmasöytisk formulering for profylakse henholdsvis for behandling av en forgiftning ved fosfororganiske cholinesterasehemmere NO962406D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4342173A DE4342173A1 (de) 1993-12-10 1993-12-10 Pharmazeutische Formulierung zur Prophylaxe bzw. Vorbehandlung einer Vergiftung durch phosphororganische Cholinesterasehemmer
PCT/EP1994/004049 WO1995015756A1 (fr) 1993-12-10 1994-12-06 Formulation pharmaceutique pour la prophylaxie ou le pretraitement d'un empoisonnement par des inhibiteurs organophosphores de la cholinesterase

Publications (2)

Publication Number Publication Date
NO962406L true NO962406L (no) 1996-06-07
NO962406D0 NO962406D0 (no) 1996-06-07

Family

ID=6504683

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962406A NO962406D0 (no) 1993-12-10 1996-06-07 Farmasöytisk formulering for profylakse henholdsvis for behandling av en forgiftning ved fosfororganiske cholinesterasehemmere

Country Status (22)

Country Link
US (1) US6114347A (fr)
EP (1) EP0732926B1 (fr)
JP (1) JP3709204B2 (fr)
KR (1) KR100374086B1 (fr)
AT (1) ATE232726T1 (fr)
AU (1) AU704020B2 (fr)
CA (1) CA2178605C (fr)
CZ (1) CZ291870B6 (fr)
DE (2) DE4342173A1 (fr)
DK (1) DK0732926T3 (fr)
ES (1) ES2193185T3 (fr)
FI (1) FI962369A (fr)
HU (1) HUT74427A (fr)
IL (1) IL111917A (fr)
MY (1) MY116828A (fr)
NO (1) NO962406D0 (fr)
NZ (1) NZ277258A (fr)
PL (1) PL314915A1 (fr)
PT (1) PT732926E (fr)
SK (1) SK282536B6 (fr)
WO (1) WO1995015756A1 (fr)
ZA (1) ZA949843B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2170649B1 (es) * 2000-03-29 2003-06-16 Ferrer Int Uso de la cdp-colina en el tratamiento de la abstinencia alcoholica.
US20030065015A1 (en) * 2001-05-11 2003-04-03 Bacaner Marvin B. Novel quarternary ammonium compositions coupled with facilitating anions and their use in kits, as well as their use in preventing and treating certain conditions
WO2003092606A2 (fr) * 2002-05-01 2003-11-13 Eisai Co., Ltd. Inhibiteurs de cholinesterase pour prevenir les blessures causees par des produits chimiques
DE10301851A1 (de) * 2003-01-17 2004-07-29 Lts Lohmann Therapie-Systeme Ag Verfahren zur medikamentösen Prophylaxe gegen Vergiftungen durch Cholinesterase-Hemmer, sowie hierfür geeignete Wirkstoffe und Arzneimittel
US20050013869A1 (en) * 2003-07-18 2005-01-20 Chaw Cheng Shu Sustained release formulation for carbamates and a method therefor
JP2007505870A (ja) * 2003-09-19 2007-03-15 イギリス国 有機リン酸中毒の治療用の医薬組成物
US9308164B2 (en) * 2004-06-30 2016-04-12 Sovereign Pharmaceuticals, Llc Hyoscyamine dosage form
US9132135B2 (en) * 2004-09-24 2015-09-15 University Of Maryland, Baltimore Method of treating organophosphorous poisoning
CN101044200A (zh) * 2004-09-24 2007-09-26 巴尔的摩马里兰大学 治疗有机磷中毒的方法
CN111773389A (zh) * 2020-06-02 2020-10-16 杨卫国 一种治疗牛中毒的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3760805A (en) * 1971-01-13 1973-09-25 Alza Corp Osmotic dispenser with collapsible supply container
US3760806A (en) * 1971-01-13 1973-09-25 Alza Corp Helical osmotic dispenser with non-planar membrane
US3764984A (en) * 1972-01-28 1973-10-09 Benz G Information coding system
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US3987790A (en) * 1975-10-01 1976-10-26 Alza Corporation Osmotically driven fluid dispenser
US4137300A (en) * 1976-08-20 1979-01-30 Ciba-Geigy Corporation Sustained action dosage forms
BE880361A (fr) * 1978-12-01 1980-05-30 Pfizer Procede de production d'acide 2-cetogulonique, de ses esters alkyliques et de ses sels
JPS60189744A (ja) * 1984-03-09 1985-09-27 Tokyo Color:Kk カラ−写真現像液の再生方法
JPS62133457A (ja) * 1985-12-04 1987-06-16 Konishiroku Photo Ind Co Ltd ハロゲン化銀カラ−写真感光材料の処理方法及び現像液処理装置
JPH03194552A (ja) * 1989-12-22 1991-08-26 Fuji Photo Film Co Ltd ハロゲン化銀カラー写真感光材料の処理方法
US5098819A (en) * 1990-01-31 1992-03-24 Knapp Audenried W Non-toxic photographic developer composition
US5278035A (en) * 1990-01-31 1994-01-11 Knapp Audenried W Non-toxic photographic developer composition for processing x-ray films in automatic film processors
DE4115558A1 (de) * 1991-05-13 1992-11-19 Dresden Arzneimittel Prophylaktisches antidot gegen phosphororganische gifte

Also Published As

Publication number Publication date
PT732926E (pt) 2003-06-30
KR100374086B1 (ko) 2003-07-23
JPH09506361A (ja) 1997-06-24
HU9601599D0 (en) 1996-08-28
DE59410246C5 (de) 2008-09-25
CZ291870B6 (cs) 2003-06-18
CZ168396A3 (en) 1996-10-16
SK282536B6 (sk) 2002-10-08
DE4342173A1 (de) 1995-06-14
PL314915A1 (en) 1996-09-30
ZA949843B (en) 1995-09-01
CA2178605C (fr) 2006-02-14
IL111917A0 (en) 1995-03-15
EP0732926A1 (fr) 1996-09-25
ATE232726T1 (de) 2003-03-15
FI962369A0 (fi) 1996-06-07
DE59410246D1 (de) 2003-03-27
AU704020B2 (en) 1999-04-15
HUT74427A (en) 1996-12-30
JP3709204B2 (ja) 2005-10-26
US6114347A (en) 2000-09-05
EP0732926B1 (fr) 2003-02-19
CA2178605A1 (fr) 1995-06-15
MY116828A (en) 2004-04-30
KR960706341A (ko) 1996-12-09
WO1995015756A1 (fr) 1995-06-15
IL111917A (en) 1998-08-16
NZ277258A (en) 1999-09-29
NO962406D0 (no) 1996-06-07
DK0732926T3 (da) 2003-06-10
SK73896A3 (en) 1996-12-04
AU1242495A (en) 1995-06-27
FI962369A (fi) 1996-08-02
ES2193185T3 (es) 2003-11-01

Similar Documents

Publication Publication Date Title
ES2128552T3 (es) Combinacion de un inhibidor de la biosintesis del colesterol y un inhibidor de la absorcion del colesterol beta-lactama.
AU5217493A (en) Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
ES2161785T3 (es) Emplasto para el tratamiento de micosis ungulares.
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
IL111942A0 (en) A transdermal therapeutic system containing a parasympathomimetic compound and a parasympatholytic compound
MX9306295A (es) Composiciones farmaceuticas para tratar sintomas de resfriado.
NO962406L (no) Farmasöytisk formulering for profylakse henholdsvis for behandling av en forgiftning ved fosfororganiske kolinesterasehemmere
ATE146677T1 (de) Pharmazeutische formulierung zur behandlung der nicotinabhängigkeit
PT752813E (pt) Inibidores de proteases de parasitas metazoarios
DK0876158T3 (da) Ny medicinsk anvendelse af en ACE-inhibitor til behandling af mavesurhedssymptomer
ATE180455T1 (de) Kindersichere verpackung für wirkstoffpflaster
ATE149793T1 (de) Fungizide zusammensetzungen
LT96094A (en) The active ingredient of pharmaceutical composition for treating constipation
ES2175153T3 (es) Uso de inhibidores de colinesterasa para la fabricacion de un medicamento para el tratamiento de la xerostomia.
MX9302986A (es) Medicamento que contiene metrifonato y procedimiento para su preparacion

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application